per day.
I couldn't see Merck saying we're going to market a drug with a safety problem.''
 It was not stopped earlier because trial results did not find increased risk in the first 18 months of the trial, the FDA said.
But the U.S. Food and Drug Administration said similar prescription drugs were safe.

